{"schema_version":"secwatch.filing_event.v1","accession":"0001753926-24-001361","form_type":"8-K","ticker":"LIPO","cik":"0001347242","company_name":"LIPELLA PHARMACEUTICALS INC.","filed_at":"2024-08-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.745935+00:00","generated_at":"2026-05-31T12:11:20.368953+00:00","sec_items":["8.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Lipella sets 2024 annual meeting for Sept 10; record date Aug 1","bullets":["Annual meeting moved to Sept 10, 2024, more than 30 days after last year's Nov 21 meeting.","Record date for voting is Aug 1, 2024.","Shareholder proposals for proxy inclusion due by Aug 8, 2024.","Director nominations and other business notices due by Aug 9, 2024.","Universal proxy rule compliance deadline also Aug 9, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001753926-24-001361","json":"https://secwatch.observer/filing/0001753926-24-001361.json","markdown":"https://secwatch.observer/filing/0001753926-24-001361.md","text":"https://secwatch.observer/filing/0001753926-24-001361.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1347242/000175392624001361/0001753926-24-001361-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1347242/000175392624001361/g084375_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T12:11:20.368953+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}